135 related articles for article (PubMed ID: 14727038)
1. [Prevention of thromboembolism in trauma surgery by dose adjustment of low molecular weight heparin depending on levels of TAT and D-dimer].
Mayer A; Hansen M; Peetz D; Hafner G; Vogel N; Prellwitz W; Rommens PM
Unfallchirurg; 2003 Dec; 106(12):1020-8. PubMed ID: 14727038
[TBL] [Abstract][Full Text] [Related]
2. A fixed-dose combination of low molecular weight heparin with dihydroergotamine versus adjusted-dose unfractionated heparin in the prevention of deep-vein thrombosis after total hip replacement.
Horbach T; Wolf H; Michaelis HC; Wagner W; Hoffmann A; Schmidt A; Beck H
Thromb Haemost; 1996 Feb; 75(2):246-50. PubMed ID: 8815569
[TBL] [Abstract][Full Text] [Related]
3. [Improved postoperative prevention of thrombosis in trauma surgery by dose adjusted low molecular weight heparin based on TAT and D-dimer values].
Hansen M; Mayer A; Peetz D; Hafner G; Prellwitz W; Rommens PM
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():1213-7. PubMed ID: 9931839
[No Abstract] [Full Text] [Related]
4. Dose-adjusted thrombosis prophylaxis in trauma surgery according to levels of D-Dimer.
Peetz D; Hafner G; Hansen M; Mayer A; Rippin G; Rommens PM; Prellwitz W
Thromb Res; 2000 Jun; 98(6):473-83. PubMed ID: 10899346
[TBL] [Abstract][Full Text] [Related]
5. Clinical utility of prothrombin fragment 1+2, thrombin antithrombin III complexes and D-dimer measurements in the diagnosis of deep vein thrombosis following total hip replacement.
Cofrancesco E; Cortellaro M; Corradi A; Ravasi F; Bertocchi F
Thromb Haemost; 1998 Mar; 79(3):509-10. PubMed ID: 9531030
[TBL] [Abstract][Full Text] [Related]
6. A comparative double-blind, randomised trial of a new second generation LMWH (bemiparin) and UFH in the prevention of post-operative venous thromboembolism. The Bemiparin Assessment group.
Kakkar VV; Howes J; Sharma V; Kadziola Z
Thromb Haemost; 2000 Apr; 83(4):523-9. PubMed ID: 10780310
[TBL] [Abstract][Full Text] [Related]
7. Coagulation activation markers in the prediction of venous thrombosis after elective hip surgery.
Cofrancesco E; Cortellaro M; Corradi A; Ravasi F; Bertocchi F
Thromb Haemost; 1997 Feb; 77(2):267-9. PubMed ID: 9157579
[TBL] [Abstract][Full Text] [Related]
8. [Prevention of venous thromboembolism in polytraumatized patients. Epidemiology and importance].
Venet C; Berger C; Tardy B; Viallon A; Decousus H; Bertrand JC
Presse Med; 2000 Jan; 29(2):68-75. PubMed ID: 10682030
[TBL] [Abstract][Full Text] [Related]
9. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
Míka P; Behounek J; Skoták M; Nevsímal L
Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
[TBL] [Abstract][Full Text] [Related]
10. Blood coagulation and thrombosis in patients with ovarian malignancy.
von Tempelhoff GF; Dietrich M; Niemann F; Schneider D; Hommel G; Heilmann L
Thromb Haemost; 1997 Mar; 77(3):456-61. PubMed ID: 9065993
[TBL] [Abstract][Full Text] [Related]
11. [Prevention of thromboembolism in surgery].
Reilmann H; Bosch U; Barthels M
Orthopade; 1988 Feb; 17(1):110-7. PubMed ID: 2836777
[TBL] [Abstract][Full Text] [Related]
12. Risk factors and coagulation parameters in relationship to phlebographic response and clinical outcome in the treatment of acute deep vein thrombosis.
Breddin HK; Kadziola Z; Scully M; Nakov R; Misselwitz F; Kakkar VV
Thromb Haemost; 2003 Feb; 89(2):272-7. PubMed ID: 12574806
[TBL] [Abstract][Full Text] [Related]
13. [Prevention of thromboembolism with low molecular weight heparin (Dalteparin-Na) in risk pregnancy].
Schinzel H; Bahlmann F; Peetz D; Savvidis S; Himmrich L; Klotz M
Med Klin (Munich); 2002 Apr; 97(4):193-203. PubMed ID: 11977574
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of thromboprophylaxis with low-molecular-weight heparin or rivaroxaban in hip and knee replacement surgery: findings from the ORTHO-TEP registry.
Beyer-Westendorf J; Lützner J; Donath L; Tittl L; Knoth H; Radke OC; Kuhlisch E; Stange T; Hartmann A; Günther KP; Weiss N; Werth S
Thromb Haemost; 2013 Jan; 109(1):154-63. PubMed ID: 23197272
[TBL] [Abstract][Full Text] [Related]
15. Thrombin-antithrombin III complex tests.
Lee SY; Niikura T; Iwakura T; Sakai Y; Kuroda R; Kurosaka M
J Orthop Surg (Hong Kong); 2017 Jan; 25(1):170840616684501. PubMed ID: 28418276
[TBL] [Abstract][Full Text] [Related]
16. Coagulation activation markers do not correlate with the clinical risk of thrombosis in pregnant women.
Bombeli T; Raddatz-Mueller P; Fehr J
Am J Obstet Gynecol; 2001 Feb; 184(3):382-9. PubMed ID: 11228491
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of an optimal dose of low-molecular-weight heparin for thromboprophylaxis in pregnant women at risk of thrombosis using coagulation activation markers.
Bombeli T; Raddatz Mueller P; Fehr J
Haemostasis; 2001; 31(2):90-8. PubMed ID: 11684864
[TBL] [Abstract][Full Text] [Related]
18. Duplex screening as a method of quality assurance of perioperative thromboembolism prophylaxis.
Van Den Berg E; Bathgate B; Panagakos E; Lambrechts R; Hani M; Meissner A; Schröder M
Int Angiol; 1999 Sep; 18(3):210-9. PubMed ID: 10688420
[TBL] [Abstract][Full Text] [Related]
19. An analysis of deep vein thrombosis in burn patients (Part 1): Comparison of D-dimer and Doppler ultrasound as screening tools.
Ahuja RB; Bansal P; Pradhan GS; Subberwal M
Burns; 2016 Dec; 42(8):1686-1692. PubMed ID: 27639819
[TBL] [Abstract][Full Text] [Related]
20. Long Term Low Molecular Weight Heparin Anticoagulant Therapy Modulates Thrombin Generation and D-dimer in Patients with Cancer and Venous Thromboembolism.
D'Alessio A; Marchetti M; Tartari CJ; Russo L; Cecchini S; Lambregts KWFM; di Mauro D; Falanga A
Cancer Invest; 2017 Aug; 35(7):490-499. PubMed ID: 28692314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
